摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-n-propylaminocyclohexanone ethylene ketal oxalate | 873536-18-6

中文名称
——
中文别名
——
英文名称
4-n-propylaminocyclohexanone ethylene ketal oxalate
英文别名
4-n-Propylaminocyclohexanone ethylene ketal oxalate;oxalic acid;N-propyl-1,4-dioxaspiro[4.5]decan-8-amine
4-n-propylaminocyclohexanone ethylene ketal oxalate化学式
CAS
873536-18-6
化学式
C2H2O4*C11H21NO2
mdl
——
分子量
289.329
InChiKey
MOSZLALDGTZASN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.83
  • 重原子数:
    20
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.85
  • 拓扑面积:
    105
  • 氢给体数:
    3
  • 氢受体数:
    7

反应信息

点击查看最新优质反应信息

文献信息

  • Method of obtaining 2-amino-6-alkyl-amino-4,5,6,7- tetrahydro-benzothiazoles
    申请人:Coca Pascual Gustavo
    公开号:US20070161798A1
    公开(公告)日:2007-07-12
    The present invention relates to a process for preparing 2-amino-6-alkyl-amino-4,5,6,7-tetrahydrobenzothiazoles (I) wherein the asterisk (*) represents an asymmetric carbon and R 1 is C 1 -C 6 alkyl; their enantiomers or mixtures thereof, their solvates, hydrates or pharmaceutically acceptable salts, comprising: (a) reacting a compound (II) with a secondary amine, optionally in the presence of an acid and a solvent 1, to form an enamine; (b) optionally removing said acid and said solvent 1, and then reacting said enamine with sulfur in the presence of a solvent 2; and (c) reacting the previously obtained compound with cyanamide to obtain the compound (I). Pramipexole, a compound with dopamine D-2 agonist activity, is among the compounds (I) and is useful for the treatment of Parkinson's disease and schizophrenia.
    本发明涉及一种制备2-氨基-6-烷基氨基-4,5,6,7-四氢苯并噻唑(I)的过程,其中星号(*)代表一个不对称碳,R1是C1-C6烷基;它们的对映体或其混合物,它们的溶剂化物,水合物或药学上可接受的盐,包括:(a)将化合物(II)与二级胺反应,可选地在酸和溶剂1的存在下,形成恩酰胺;(b)可选地除去所述酸和所述溶剂1,然后在溶剂2的存在下将所述恩酰胺与硫反应;(c)将先前获得的化合物与氰胺反应以获得化合物(I)。普拉米柏索尔是化合物(I)之一,具有多巴胺D-2激动剂活性,可用于治疗帕金森病和精神分裂症。
  • METHOD OF OBTAINING 2-AMINO-6-ALKYL-AMINO-4,5,6,7- TETRAHYDROBENZOTHIAZOLES
    申请人:Pascual Coca Gustavo
    公开号:US20100063324A1
    公开(公告)日:2010-03-11
    The present invention relates to a process for preparing 2-amino-6-alkyl-amino-4,5,6,7-tetrahydrobenzothiazoles (I) wherein the asterisk (*) represents an asymmetric carbon and R 1 is C 1 -C 6 alkyl; their enantiomers or mixtures thereof, their solvates, hydrates or pharmaceutically acceptable salts, comprising: (a) reacting a compound (II) with a secondary amine, optionally in the presence of an acid and a solvent 1, to form an enamine; (b) optionally removing said acid and said solvent 1, and then reacting said enamine with sulfur in the presence of a solvent 2; and (c) reacting the previously obtained compound with cyanamide to obtain the compound (I). Pramipexole, a compound with dopamine D-2 agonist activity, is among the compounds (I) and is useful for the treatment of Parkinson's disease and schizophrenia.
    本发明涉及一种制备2-氨基-6-烷基氨基-4,5,6,7-四氢苯并噻唑(I)的方法,其中星号(*)代表一个不对称的碳原子,R1是C1-C6烷基;它们的对映异构体或其混合物,它们的溶剂化物,水合物或药学上可接受的盐,包括:(a)将化合物(II)与二级胺反应,可选地在酸和溶剂1的存在下,形成烯胺;(b)可选地去除所述酸和所述溶剂1,然后在溶剂2的存在下将所述烯胺与硫反应;以及(c)将先前获得的化合物与氰胺反应以获得化合物(I)。普拉米柏索尔是化合物(I)之一,具有多巴胺D-2激动剂活性,可用于治疗帕金森病和精神分裂症。
  • Method of obtaining 2-amino-6-alkyl-amino-4,5,6,7-tetrahydrobenzothiazoles
    申请人:Ragactives, S.L.
    公开号:US07875750B2
    公开(公告)日:2011-01-25
    The present invention relates to a process for preparing 2-amino-6-alkyl-amino-4,5,6,7-tetrahydrobenzothiazoles (I) wherein the asterisk (*) represents an asymmetric carbon and R1 is C1-C6 alkyl; their enantiomers or mixtures thereof, their solvates, hydrates or pharmaceutically acceptable salts, comprising: (a) reacting a compound (II) with a secondary amine, optionally in the presence of an acid and a solvent 1, to form an enamine; (b) optionally removing said acid and said solvent 1, and then reacting said enamine with sulfur in the presence of a solvent 2; and (c) reacting the previously obtained compound with cyanamide to obtain the compound (I). Pramipexole, a compound with dopamine D-2 agonist activity, is among the compounds (I) and is useful for the treatment of Parkinson's disease and schizophrenia.
    本发明涉及一种制备2-氨基-6-烷基氨基-4,5,6,7-四氢苯并噻唑(I)的过程,其中星号(*)表示不对称碳,R1为C1-C6烷基;它们的对映体或其混合物、它们的溶剂化物、水合物或药学上可接受的盐,包括:(a)将化合物(II)与二级胺反应,可选地在酸和溶剂1的存在下,形成烯胺;(b)可选地去除所述酸和所述溶剂1,然后在溶剂2的存在下将所述烯胺与硫反应;以及(c)将先前获得的化合物与氰胺反应,以获得化合物(I)。普拉米柏索尔是化合物(I)中具有多巴胺D-2激动剂活性的化合物之一,适用于治疗帕金森病和精神分裂症。
  • Method of obtaining 2-amino-6-alkyl-amino-4,5,6,7-tetrahydro-benzothiazoles
    申请人:Ragactives, S.L.
    公开号:US07638542B2
    公开(公告)日:2009-12-29
    A process for preparing 2-amino-6-alkyl-amino-4,5,6,7-tetrahydrobenzothiazoles of formula (I) wherein the asterisk (*) represents an asymmetric carbon and R1 is C1-C6 alkyl; and enantiomers and mixtures thereof, and their solvates, hydrates and pharmaceutically acceptable salts. The process involves (a) reacting with a secondary amine, optionally in the presence of an acid and a first solvent, to form an enamine; (b) optionally removing the acid and first solvent, and then reacting the enamine with sulfur in the presence of a second solvent; and (c) reacting the previously obtained compound with cyanamide to obtain the formula (I) compound. Pramipexole, a dopamine D-2 agonist, can be made by such process, and is useful for the treatment of Parkinson's disease and schizophrenia.
    一种制备式(I)的2-氨基-6-烷基-氨基-4,5,6,7-四氢苯并噻唑的过程,其中星号(*)代表不对称碳,R1为C1-C6烷基;以及其对映体和混合物、其溶剂化物、水合物和药学上可接受的盐。该过程包括(a)与二级胺反应,可选地在酸和第一溶剂的存在下,形成烯胺;(b)可选地去除酸和第一溶剂,然后在第二溶剂的存在下,将烯胺与硫反应;(c)将先前得到的化合物与氰胺反应,得到式(I)化合物。普拉米柏索尔是一种多巴胺D-2激动剂,可以通过这种过程制备,用于治疗帕金森病和精神分裂症。
  • METHOD OF OBTAINING 2-AMINO-6-ALKYL-AMINO-4,5,6,7-TETRAHYDROBENZOTHIAZOLES
    申请人:Ragactives, S.L.
    公开号:EP1783120B1
    公开(公告)日:2009-05-06
查看更多